Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic target

American Journal of Cardiology

Volumn 91, Issue 10 SUPPL. 1, 2003, Pages 9-14

  Healey, Jeff S ^a   Connolly, Stuart J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; LABETALOL; LISINOPRIL; PRAZOSIN; TRANDOLAPRIL; VERAPAMIL; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; CATHETER ABLATION; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; HEART ATRIUM CONDUCTION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HEART RATE; HEART RHYTHM; HEART VENTRICLE FAILURE; HEART VENTRICLE FILLING; HUMAN; HYPERTENSION; META ANALYSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY VEIN; REVIEW; STROKE; SUPRAVENTRICULAR PREMATURE BEAT; THROMBOEMBOLISM;

EID: 0038777176     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00227-3     Document Type: Review

References (63)

1. Wilhelmsen L., Rosengren A., Lappas G. Hospitalizations for atrial fibrillation in the general male population morbidity and risk factors . J Intern Med. 250:2001;382-389.
2. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation analysis and implications . Arch Intern Med. 155:1995;469-473.
3. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 96:1997;2455-2461.
4. Kannel W.B., Wolf P.A., Benjamin E.J., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation population-based estimates . Am J Cardiol. 82:(suppl):1998;2N-9N.
5. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation the Framingham study . N Engl J Med. 306:1982;1018-1022.
6. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., Horan M.J., Labarthe D. Prevalence of hypertension in the US adult population results from the Third National Health and Nutrition Examination Survey, 1988-1991 . Hypertension. 25:1995;305-313.
7. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E. The natural history of atrial fibrillation incidence, risk factors, and prognosis in the Manitoba Follow-Up Study . Am J Med. 98:1995;476-484.
8. Ciaroni S., Cuenoud L., Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J. 139:2000;814-819.
9. Wolf P.A., Dawber T.R., Thomas H.E. Jr, Kannel W.B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke the Framingham study . Neurology. 28:1978;973-977.
10. Hart R.G., Coull B.M., Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation a retrospective study . Stroke. 14:1983;688-693.
11. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation a major contributor to stroke in the elderly: the Framingham Study . Arch Intern Med. 147:1987;1561-1564.
12. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke the Framingham Study . Stroke. 22:1991;983-988.
13. Peterson P., Godtfredson J. Embolic complications in paroxysmal atrial fibrillation. Stroke. 17:1986;622-626.
14. Tohgi H., Tajima T., Konno T., Towada S., Kamata A., Yamazaki M. The risk of cerebral infarction in non-valvular atrial fibrillation effects of age, hypertension and antihypertensive treatment . Eur Neurol. 31:1991;126-130.
15. Predictors of thromboembolism in atrial fibrillation: II. echocardiographic features of patients at risk. Ann Intern Med. 116:1992;6-12.
16. Miller J.T., O'Rourke R.A., Crawford M.H. Left atrial enlargement an early sign of hypertensive heart disease . Am Heart J. 116:1988;1048-1051.
17. Tedesco M.A., Di Salvo G., Ratti G., Natale F., Iarussi D., Iacono A. Left atrial size in 164 hypertensive patients an echocardiographic and ambulatory blood pressure study . Clin Cardiol. 24:2001;603-607.
18. Gerdts E., Oikarinen L., Palmieri V., Otterstad J.E., Wachtell K., Boman K., Dahlof B., Devereux R.B. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study . Hypertension. 39:2002;739-743.
19. Galderisi M., Petrocelli A., Fakher A., Izzo A., Alfieri A., de Divitiis O. Influence of nighttime blood pressure on left atrial size in uncomplicated arterial systemic hypertension. Am J Hypertens. 10:1997;836-842.
20. Vaziri S.M., Larson M.G., Lauer M.S., Benjamin E.J., Levy D. Influence of blood pressure on left atrial size the Framingham Heart Study . Hypertension. 25:1995;1155-1160.
21. Valdez R.S., Motta J.A., London E., Martin R.P., Haskell W.L., Farquhar J.W., Popp R.L., Horlick L. Evaluation of the echocardiogram as an epidemiologic tool in an asymptomatic population. Circulation. 60:1979;921-929.
22. Appleton C.P., Galloway J.M., Gonzalez M.S., Gaballa M., Basnight M.A. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction . J Am Coll Cardiol. 22:1993;1972-1982.
23. Matsuda M., Matsuda Y. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension. Clin Cardiol. 19:1996;954-959.
24. Dreslinski G.R., Frohlich E.D., Dunn F.G., Messerli F.H., Suarez D.H., Reisin E. Echocardiographic diastolic ventricular abnormality in hypertensive heart disease atrial emptying index . Am J Cardiol. 47:1981;1087-1090.
25. Smith V.E., Schulman P., Karimeddini M.K., White W.B., Meeran M.K., Katz A.M. Rapid ventricular filling in left ventricular hypertrophy II. pathologic hypertrophy . J Am Coll Cardiol. 5:1985;869-874.
26. Inouye I., Massie B., Loge D., Topic N., Silverstein D., Simpson P., Tubau J. Abnormal left ventricular filling an early finding in mild to moderate systemic hypertension . Am J Cardiol. 53:1984;120-126.
27. Barbier P., Alioto G., Guazzi M.D. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 24:1994;165-170.
28. Tsang T.S., Barnes M.E., Bailey K.R., Leibson C.L., Montgomery S.C., Takemoto Y., Diamond P.M., Marra M.A., Gersh B.J., Wiebers D.O., Petty G.W., Seward J.B. Left atrial volume important risk marker of incident atrial fibrillation in 1655 older men and women . Mayo Clin Proc. 76:2001;467-475.
29. Lutas E.M., Devereux R.B., Reis G., Alderman M.H., Pickering T.G., Borer J.S., Laragh J.H. Increased cardiac performance in mild essential hypertension left ventricular mechanics . Hypertension. 7:1985;979-988.
30. Pearson A.C., Gudipati C., Nagelhout D., Sear J., Cohen J.D., Labovitz A.J. Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol. 17:1991;422-430.
31. Pozzoli M., Cioffi G., Traversi E., Pinna G.D., Cobelli F., Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure a prospective study in 344 patients with baseline sinus rhythm . J Am Coll Cardiol. 32:1998;197-204.
32. Shi Y., Li D., Tardif J.C., Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res. 54:2002;456-461.
33. Madu E.C., Baugh D.S., Gbadebo T.D., Dhala A., Cardoso S. Effect of ethnicity and hypertension on atrial conduction evaluation with high-resolution P-wave signal averaging . Clin Cardiol. 24:2001;597-602.
34. Fukunami M., Yamada T., Ohmori M., Kumagai K., Umemoto K., Sakai A., Kondoh N., Minamino T., Hoki N. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation. 83:1991;162-169.
35. Guidera S.A., Steinberg J.S. The signal-averaged P wave duration a rapid and noninvasive marker of risk of atrial fibrillation . J Am Coll Cardiol. 21:1993;1645-1651.
36. Satoh T., Zipes D.P. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 7:1996;833-842.
37. Stafford P.J., Turner I., Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol. 68:1991;751-755.
38. Solti F., Vecsey T., Kekesi V., Juhasz-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res. 23:1989;882-886.
39. Ravelli F., Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 96:1997;1686-1695.
40. Daoud E.G., Bogun F., Goyal R., Harvey M., Man K.C., Strickberger S.A., Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 94:1996;1600-1606.
41. Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation a study in awake chronically instrumented goats . Circulation. 92:1995;1954-1968.
42. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Metayer P., Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 339:1998;659-666.
43. Nathan H., Eliakim M. The junction between the left atrium and the pulmonary veins an anatomic study of human hearts . Circulation. 34:1966;412-422.
44. Ho S.Y., Sanchez-Quintana D., Cabrera J.A., Anderson R.H. Anatomy of the left atrium implications for radiofrequency ablation of atrial fibrillation . J Cardiovasc Electrophysiol. 10:1999;1525-1533.
45. Loaldi A., Pepi M., Agostoni P.G., Fiorentini C., Grazi S., Della Bella P., Guazzi M.D. Cardiac rhythm in hypertension assessed through 24 hour ambulatory electrocardiographic monitoring effects of load manipulation with atenolol, verapamil, and nifedipine . Br Heart J. 50:1983;118-126.
46. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kay G.N., Klein W.W., Levy S., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology . J Am Coll Cardiol. 38:2001;1231-1266.
47. Schmieder R.E., Schlaich M.P., Klingbeil A.U., Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant. 13:1998;564-569.
48. Gottdiener J.S., Reda D.J., Williams D.W., Materson B.J., Cushman W., Anderson R.J. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension comparison of six antihypertensive agents . Circulation. 98:1998;140-148.
49. Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K.H., Wedel H., Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension principal results of the Hypertension Optimal Treatment (HOT) randomised trial: HOT Study Group . Lancet. 351:1998;1755-1762.
50. Neal B., MacMahon S., Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs results of prospectively designed overviews of randomised trials: Blood Pressure Lowering Treatment Trialists' Collaboration . Lancet. 356:2000;1955-1964.
51. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,015 individuals with previous stroke or transient ischaemic attack. Lancet. 358:2001;1033-1041.
52. Liebson P.R. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens. 3:1990;512-517.
53. Dahlof B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients a metaanalysis of 109 treatment studies . Am J Hypertens. 5:1992;95-110.
54. Schulman S.P., Weiss J.L., Becker L.C., Gottlieb S.O., Woodruff K.M., Weisfeldt M.L., Gerstenblith G. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 322:1990;1350-1356.
55. Qian X.X., Chen A.H., Deng J.Y., Tang X.M., Liu Y.F., Li Z.L., Ou S.B., Wu Z.N., Wang K.R. The effect of Isoptin SR on blood pressure, heart function and hypertrophy of left ventricle of hypertensive patients. Chin Med J (Engl). 107:1994;260-264.
56. Schulman D.S., Flores A.R., Tugoen J., Dianzumba S., Reichek N. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function. Am J Cardiol. 78:1996;56-60.
57. 2+ blocker verapamil (Calan-SR) in hypertensive patients. J Cardiovasc Pharmacol. 22:1993;637-643.
58. Kaul U., Mohan J.C., Bhatia M.L. Effects of labetalol on left ventricular mass and function in hypertension an assessment by serial echocardiography . Int J Cardiol. 5:1984;461-473.
59. Pedersen O.D., Bagger H., Køber L., Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 100:1999;376-380.
60. Madrid A.H., Bueno M.G., Rebollo J.M., Marin I., Pena G., Bernal E., Rodriguez A., Cano L., Cano J.M., Cabeza P., Moro C. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study . Circulation. 106:2002;331-336.
61. Van Den Berg M.P., Crijns H.J., van Veldhuisen D.J. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail. 1:1995;355-363.
62. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized controlled trials . Arch Intern Med. 154:1994;1449-1457.
63. Bosch J., Yusuf S., Pogue J., Sleight P., Lonn E., Rangoonwala B., Davies R., Ostergren J., Probstfield J. Use of ramipril in preventing stroke double blind randomised trial . BMJ. 324:2002;699-702.